Tissue Regenix Group plc Common Stock

The latest common stock for TSSNF is $92K as of December 2024. That compares with $91K in the prior-year period — up 1.1% year over year. Investors often review this figure alongside Tissue Regenix Group plc's historical trend and sector peers before judging valuation or financial health.

Over the past year, TSSNF's common stock moved from $91K to $92K — a 1.1% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Tissue Regenix Group plc's operating scale or balance-sheet position.

A common stock figure of $92K for TSSNF is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting TSSNF's common stock ($92K), review year-over-year change from $91K, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.